Enables Whole-Transcriptome In Situ Spatial Biology with Single-Cell Sensitivity at Scale Debuts at AACR Annual Meeting 2026 with Data from Leading Research Institutions, Including the June Lab at the Perelman School of Medicine, University of Pennsylvania and German Cancer Research Institute (DKFZ) PLEASANTON, Calif. — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, […]

Saint Germain-en-Laye, France, San José, USA, and Helsinki, Finland – Life Science Newswire – Takara Bio and Resistomap Oy today announce a strategic agreement to deepen their partnership in developing streamlined end-to-end solutions for high throughput antimicrobial resistance (AMR) surveillance from environmental samples. This collaboration unites Takara Bio’s scalable instrumentation with Resistomap’s environmental AMR intelligence to address […]

Partnership highlights streamlined spatial biology workflows combining advanced multiplex IF reagents and AI-powered image analysis OBERKOCHEN, Germany — Revolune GmbH, a life science company focused on simplifying spatial biology through streamlined multiplex immunofluorescence (mIF) reagents, today announced it will exhibit at the American Association for Cancer Research (AACR) Annual Meeting 2026 together with MindPeak, a leader in AI-powered pathology analysis. […]

Bioluminescence tools, companion diagnostics and automated sample preparation headline Promega presence at AACR 2026 MADISON, Wis. — Promega Corporation, a Madison, Wisconsin-based life science tools company, will present new technologies for cell health, target engagement and oncology diagnostics at the AACR Annual Meeting 2026 in San Diego, April 17-22. Researchers attending the conference can explore […]

Highlights solutions addressing key oncology research needs across automated sample preparation, single-cell analysis, genomic profiling and data analysis QIAsymphony Connect will serve as a foundation for lab workflows, enabling standardized nucleic acid extraction for clinical and translational research Introduction of the QIAGEN Discovery Platform, an AI-grounding solution to power downstream AI applications and support drug […]

Nanion Technologies GmbH Munich, Germany Following several years of close collaboration, Nanion Technologies and Elements are proud to announce the successful integration of Elements’ cutting-edge microchip-based amplifier technology into Nanion’s newly launched Patchlinere and Patchlinerm platforms. Driving innovation in electrophysiology Nanion has long been committed to advancing automated patch clamp technologies to accelerate drug discovery […]

Acquisition of CareDx’s ‘lab products’ portfolio creates new opportunities for growth and innovation in the fast growing transplant diagnostics market Acceleration of Eurobio’s strategic plan to become an in-vitro molecular diagnostics (“IVD”) leader Creation of a global leading provider of kits for transplantation genomics Acquisition of a 100% proprietary products portfolio Deeper capabilities and larger […]

Illumina launches DRAGEN v4.5, unlocking deep biological signals in complex regions and challenging sample types for rare disease, oncology research New pangenome representation, default personalization, and machine learning features boost analytical capabilities across applications SAN DIEGO — Illumina Inc. (NASDAQ: ILMN) today announced the launch of DRAGEN™ version 4.5 software (v4.5), one of the most […]

A next-generation PCR system designed to help labs manage increasing workflow complexity with greater flexibility, speed and confidence in reproducible results WALTHAM, Mass. — Thermo Fisher Scientific Inc., the world leader in serving science, today announced the Applied Biosystems™ PowerFlex™ Thermal Cycler, a next-generation polymerase chain reaction (PCR) instrument designed to help deliver enhanced flexibility, […]

SAN DIEGO and NEW YORK — SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, today announced that the Mount Sinai Health System, one of the leading academic health systems in the United States, will adopt the AI-powered SOPHiA DDM™ Platform to advance cancer research and enhance genomic testing capabilities. Mount Sinai, a National […]